Wall Street brokerages predict that Cavium Inc (NASDAQ:CAVM) will report earnings of $0.75 per share for the current fiscal quarter, according to Zacks. Five analysts have provided estimates for Cavium’s earnings. The highest EPS estimate is $0.81 and the lowest is $0.69. Cavium reported earnings of $0.58 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 29.3%. The business is scheduled to report its next quarterly earnings report on Wednesday, April 25th.
According to Zacks, analysts expect that Cavium will report full year earnings of $3.58 per share for the current financial year, with EPS estimates ranging from $3.40 to $3.67. For the next financial year, analysts expect that the firm will post earnings of $4.55 per share, with EPS estimates ranging from $4.41 to $4.81. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research firms that follow Cavium.
Cavium (NASDAQ:CAVM) last issued its quarterly earnings results on Wednesday, January 31st. The semiconductor provider reported $0.83 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.81 by $0.02. The company had revenue of $260.36 million during the quarter, compared to the consensus estimate of $260.05 million. Cavium had a positive return on equity of 14.28% and a negative net margin of 7.00%. Cavium’s revenue was up 15.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.56 EPS.
Cavium (CAVM) traded down $0.53 during mid-day trading on Friday, hitting $86.57. The stock had a trading volume of 1,624,777 shares, compared to its average volume of 1,004,642. The firm has a market cap of $6,023.46, a P/E ratio of -84.87, a price-to-earnings-growth ratio of 2.13 and a beta of 1.33. The company has a current ratio of 2.87, a quick ratio of 2.27 and a debt-to-equity ratio of 0.81. Cavium has a 1-year low of $56.96 and a 1-year high of $90.83.
In related news, VP Anil Kumar Jain sold 8,500 shares of the company’s stock in a transaction on Tuesday, November 21st. The shares were sold at an average price of $85.90, for a total transaction of $730,150.00. Following the completion of the sale, the vice president now directly owns 91,616 shares of the company’s stock, valued at approximately $7,869,814.40. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Vincent P. Pangrazio sold 15,000 shares of the company’s stock in a transaction on Friday, November 10th. The stock was sold at an average price of $77.22, for a total transaction of $1,158,300.00. Following the sale, the senior vice president now directly owns 60,039 shares of the company’s stock, valued at $4,636,211.58. The disclosure for this sale can be found here. 4.65% of the stock is currently owned by corporate insiders.
Large investors have recently bought and sold shares of the business. SG Americas Securities LLC purchased a new position in Cavium in the 4th quarter valued at about $115,000. Cerebellum GP LLC purchased a new position in Cavium in the 4th quarter valued at about $126,000. US Bancorp DE boosted its position in Cavium by 201.3% in the 4th quarter. US Bancorp DE now owns 1,657 shares of the semiconductor provider’s stock valued at $139,000 after buying an additional 1,107 shares during the last quarter. World Asset Management Inc purchased a new position in Cavium in the 3rd quarter valued at about $203,000. Finally, Comerica Bank purchased a new position in Cavium in the 4th quarter valued at about $227,000. 99.05% of the stock is owned by institutional investors.
Cavium, Inc is a provider of integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage and security applications. The Company’s products consist of multi-core processors for embedded and data center applications, network connectivity for server and switches, storage connectivity, and security processors for offload and appliance.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cavium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium and related companies with MarketBeat.com's FREE daily email newsletter.